PMID- 35083387 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220128 IS - 2434-0790 (Electronic) IS - 2434-0790 (Linking) VI - 4 IP - 1 DP - 2022 Jan 7 TI - Local Injection of Hydroxyapatite Electret Ameliorated Infarct Size After Myocardial Infarction. PG - 38-47 LID - 10.1253/circrep.CR-21-0100 [doi] AB - Background: Previous studies showed that hydroxyapatite electret (HAE) accelerates the regeneration of vascular endothelial cells and angiogenesis. This study investigated the effects of HAE in myocardial infarction (MI) model mice. Methods and Results: MI was induced in mice by ligating the left anterior descending artery. Immediately after ligation, HAE, non-polarized hydroxyapatite (HAN), or water (control) was injected into the infarct border myocardium. Functional and histological analyses were performed 2 weeks later. Echocardiography revealed that HAE injection preserved left ventricular systolic function and the wall thickness of the scar, whereas HAN-injected mice had impaired cardiac function and thinning of the wall, similar to control mice. Histological assessment showed that HAE injection significantly attenuated the length of the scar lesion. There was significant accumulation of CD31-positive cells and increased expression of vascular endothelial growth factor (Vegf), intercellular adhesion molecule-1 (Icam1), vascular cell adhesion molecule-1 (Vcam1), hypoxia-inducible factor-1alpha (Hif1a), and C-X-C motif chemokine ligand 12 (Cxcl12) genes in the infarct border zone of HAE-injected mice. These effects were not induced by HAN injection. Anti-VEGFR2 antibody canceled the beneficial effect of HAE. In vitro experiments in a human cardiovascular endothelial cell line showed that HAE dose-dependently increased VEGFA expression. Conclusions: Local injection of HAE attenuated infarct size and improved cardiac function after MI, probably due to angiogenesis. The electric charge of HAE may stimulate angiogenesis via HIF1alpha-CXCL12/VEGF signaling. CI - Copyright (c) 2022, THE JAPANESE CIRCULATION SOCIETY. FAU - Yamaguchi, Junji AU - Yamaguchi J AD - Department of Cardiovascular Medicine, Tokyo Medical and Dental University Tokyo Japan. FAU - Chiba, Risako AU - Chiba R AD - Department of Cardiovascular Physiology, Tokyo Medical and Dental University Tokyo Japan. FAU - Komuro, Hiroaki AU - Komuro H AD - Department of Cardiovascular Physiology, Tokyo Medical and Dental University Tokyo Japan. FAU - Ihara, Kensuke AU - Ihara K AD - Department of Bio-informational Pharmacology, Medical Research Institute, Tokyo Medical and Dental University Tokyo Japan. FAU - Nozaki, Kosuke AU - Nozaki K AD - Department of Fixed Prosthodontics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University Tokyo Japan. FAU - Nagai, Akiko AU - Nagai A AD - Department of Anatomy, Aichi-Gakuin University School of Dentistry Nagoya Japan. FAU - Furukawa, Tetsushi AU - Furukawa T AD - Department of Bio-informational Pharmacology, Medical Research Institute, Tokyo Medical and Dental University Tokyo Japan. FAU - Sasano, Tetsuo AU - Sasano T AD - Department of Cardiovascular Medicine, Tokyo Medical and Dental University Tokyo Japan. LA - eng PT - Journal Article DEP - 20211201 PL - Japan TA - Circ Rep JT - Circulation reports JID - 101746642 PMC - PMC8710644 OTO - NOTNLM OT - Angiogenesis OT - Hydroxyapatite electret OT - Myocardial infarction OT - Ventricular remodeling COIS- The authors have no conflicts of interest to declare. EDAT- 2022/01/28 06:00 MHDA- 2022/01/28 06:01 PMCR- 2021/12/01 CRDT- 2022/01/27 05:50 PHST- 2021/07/16 00:00 [received] PHST- 2021/11/01 00:00 [revised] PHST- 2021/11/04 00:00 [accepted] PHST- 2022/01/27 05:50 [entrez] PHST- 2022/01/28 06:00 [pubmed] PHST- 2022/01/28 06:01 [medline] PHST- 2021/12/01 00:00 [pmc-release] AID - 10.1253/circrep.CR-21-0100 [doi] PST - epublish SO - Circ Rep. 2021 Dec 1;4(1):38-47. doi: 10.1253/circrep.CR-21-0100. eCollection 2022 Jan 7.